Chemistry:Leflutrozole

From HandWiki
Short description: Chemical compound
Leflutrozole
Leflutrozole.svg
Clinical data
Other namesBGS-649; CGP-47645
Routes of
administration
By mouth
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC17H10FN5
Molar mass303.300 g·mol−1
3D model (JSmol)

Leflutrozole (developmental code names BGS-649, CGP-47645) is an aromatase inhibitor which is under development by Mereo BioPharma and Novartis for the treatment of hypogonadism in men.[1] It was also under investigation for the treatment of endometriosis, but development for this indication was discontinued.[1] As of December 2017, leflutrozole is in phase II clinical trials for hypogonadism.[1]

See also

References

External links